| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/31/2002 | CN1360937A Nanometer rhinitis treating medicine and its prepn |
| 07/31/2002 | CN1360936A Nanometer Yunnan Baiyao medicine and its prepn |
| 07/31/2002 | CN1360935A Nanometer motherwort medicine and its prepn |
| 07/31/2002 | CN1360934A Nanometer Baofukang medicine for women's health and its prepn |
| 07/31/2002 | CN1360933A Nanometer leukorrhea treating medicine and its prepn |
| 07/31/2002 | CN1360932A Nanometer breast nodule-eliminating medicine and its prepn |
| 07/31/2002 | CN1360931A Nanometer luminous Dendrobium nobil medicine and its prepn |
| 07/31/2002 | CN1360930A Nanometer traumatic injury-treating medicine and its prepn |
| 07/31/2002 | CN1360929A Nanometer nasosinusitis treating medicine and its prepn |
| 07/31/2002 | CN1360928A Nanometer Fuyanping medicine and its prepn |
| 07/31/2002 | CN1360927A Nanometer Fule medicine for women and its prepn |
| 07/31/2002 | CN1360926A Nanometer menstruction regulation Chinese angelica medicine and its prepn |
| 07/31/2002 | CN1360922A Externally applied pain-relieving plaster and its prepn |
| 07/31/2002 | CN1360921A Nanometer eyesight improving adhesive rehmannia medicine and its prepn |
| 07/31/2002 | CN1360920A Nanometer antiphlogistic Lonicerae and Forsythiae medicine and its prepn |
| 07/31/2002 | CN1360919A Nanometer Guxian medicine and its prepn |
| 07/31/2002 | CN1360918A Nanometer zhuhuang medicine and its prepn |
| 07/31/2002 | CN1360917A Nanoemter alopecia treating medicine and its prepn |
| 07/31/2002 | CN1360916A Nanometer zhangyanming medicine for treating eye disease and its prepn |
| 07/31/2002 | CN1360915A Nanometer zuoci medicine for treating deafness and its prepn |
| 07/31/2002 | CN1360914A Nanometer Aifunuangong preparation medicine for warming womb and its preparing method |
| 07/31/2002 | CN1360913A Nanometer Xiaojing medicine and its prepn |
| 07/31/2002 | CN1360912A Nanometer spur treating medicine and its prepn |
| 07/31/2002 | CN1360911A Nanometer threewingnut medicine and its prepn |
| 07/31/2002 | CN1360910A Nanometer xiaoyao medicine preparation and its preparing method |
| 07/31/2002 | CN1360909A Nanometer cinobufagin medicine and its prepn |
| 07/31/2002 | CN1360905A Cancer treating astringent medicine decoction |
| 07/31/2002 | CN1360904A Mongolian medicine ointment for treating psoriasis |
| 07/31/2002 | CN1360902A Blood lipoid regulating medicine and its prepn |
| 07/31/2002 | CN1360901A Snuff xinnaokang for treating cardiovascular and cerebrovascular disease |
| 07/31/2002 | CN1360898A Prepn of Baoxinning tablet as angiocardiopathy treating medicine |
| 07/31/2002 | CN1360892A Dry mixed suspension of Meptin and pseudoephe and its prepn |
| 07/31/2002 | CN1088372C Method for producing aloe tablets |
| 07/31/2002 | CN1088371C Hair-blackening and hair-growing capsule |
| 07/31/2002 | CN1088370C Tonguan shugan ointment and preparation process thereof |
| 07/31/2002 | CN1088367C Colour-restoring ointment for treating burn or scald |
| 07/31/2002 | CN1088362C Method of administering azithromycin |
| 07/31/2002 | CN1088360C High efficient anti-inflammatory and antipruritic ointment and its producing method |
| 07/31/2002 | CN1088358C Antitussive composition containing antitussive and benzydamine |
| 07/31/2002 | CN1088357C Microgranules of 5-nitro imidazole derivatives |
| 07/31/2002 | CN1088356C Comedo-extracting plastering sheet |
| 07/30/2002 | US6427088 Ambulatory medical apparatus and method using telemetry system with predefined reception listening periods |
| 07/30/2002 | US6426444 Disposable product |
| 07/30/2002 | US6426363 Mixture containing triglyceride, surfactants |
| 07/30/2002 | US6426358 Inhibition of noninactivating Na channels of mammalian optic nerve as a means of preventing optic nerve degeneration associated with glaucoma |
| 07/30/2002 | US6426339 In situ; sustained release; preadministering glucocorticosteroid |
| 07/30/2002 | US6426336 Method for treating allergic lung disease |
| 07/30/2002 | US6426214 Cell encapsulating device containing a cell displacing core for maintaining cell viability |
| 07/30/2002 | US6426210 Storage of materials |
| 07/30/2002 | US6426208 Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 07/30/2002 | US6426098 Herbal compositions for hepatic disorders |
| 07/30/2002 | US6426092 Powder compositions comprising a skin irritation reducing agent |
| 07/30/2002 | US6426091 Sustained-release theophylline tablet |
| 07/30/2002 | US6426090 Over-coated product including tableted center and medicament |
| 07/30/2002 | US6426089 Multilayered soft capsule for eliminating bad breath and process for producing the same |
| 07/30/2002 | US6426088 Sustained release; in situ insertion |
| 07/30/2002 | US6426087 Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent |
| 07/30/2002 | US6426086 pH-sensitive, serum-stable liposomes |
| 07/30/2002 | US6426085 Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis |
| 07/30/2002 | US6426079 Mixture of silicone oil and polyethsiloxane copolymer |
| 07/30/2002 | US6426078 Oil in water microemulsion |
| 07/30/2002 | US6426066 Use of physiologically balanced, ionized, acidic solution in wound healing |
| 07/30/2002 | US6425918 Polysaccharide sponges for cell culture and transplantation |
| 07/30/2002 | US6425904 Medical devices using electrosensitive gels |
| 07/30/2002 | CA2236021C Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities: process of making metho ds of using and compositions thereof |
| 07/30/2002 | CA2209714C A controlled release formulation for poorly soluble basic drugs |
| 07/30/2002 | CA2151956C Encapsulation apparatus and process |
| 07/30/2002 | CA2097163C Topical patch for liposomal drug delivery system |
| 07/30/2002 | CA2082573C Solid depot drug form |
| 07/30/2002 | CA2068061C Waterproof high-spf sunscreen compositions |
| 07/30/2002 | CA2062428C Low dose dry pharmaceutical preparations |
| 07/30/2002 | CA2042529C Polysaccharide article and uses therefor |
| 07/30/2002 | CA2039052C Process for preparing piroxicam/cyclodextrin complexes, the products obtained and their pharmaceutical compositions |
| 07/26/2002 | CA2369268A1 Pharmaceutical dosage forms with enhanced cohesive and compressibility properties |
| 07/25/2002 | WO2002057436A2 Red blood cell from a transgenic animal as vehicle for polypeptide delivery |
| 07/25/2002 | WO2002057424A2 Nucleic acid delivery formulations |
| 07/25/2002 | WO2002057267A1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof |
| 07/25/2002 | WO2002057260A1 Compounds for use in the treatment of skin conditions |
| 07/25/2002 | WO2002057211A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
| 07/25/2002 | WO2002057011A1 Dehydrating agent and method for dehydrating moist article using the agent and dehydrated article obtained by the method |
| 07/25/2002 | WO2002056932A2 Thermal vaporizing device for drug delivery |
| 07/25/2002 | WO2002056915A2 Complex of modafinil and cyclodextrin |
| 07/25/2002 | WO2002056914A1 Injections for endoscopy |
| 07/25/2002 | WO2002056913A2 Stabilized brivudine topical formulations containing metal oxide pigments |
| 07/25/2002 | WO2002056908A2 Artificial antigen-presenting cells |
| 07/25/2002 | WO2002056896A2 Treatment solution in addition to dressing material for caring for wounds |
| 07/25/2002 | WO2002056890A1 Novel method and compositions for local treatment of meniere's disease, tinnitus and/or hearing loss |
| 07/25/2002 | WO2002056883A1 Preparation of micron-size felodipine particles by microfluidization |
| 07/25/2002 | WO2002056881A1 Fenofibrate tablets |
| 07/25/2002 | WO2002056879A1 Use of terpenes for the treatment of digestive tract infections |
| 07/25/2002 | WO2002056878A2 Pharmaceutical composition having reduced tendency for drug crystallization |
| 07/25/2002 | WO2002056877A1 Treatment of sleep disturbances |
| 07/25/2002 | WO2002056876A2 Treatment for snoring |
| 07/25/2002 | WO2002056875A2 Method of treatment of dopamine-related dysfunction through administration of a full d1 dopamine receptor agonist and with no induction of tolerance |
| 07/25/2002 | WO2002056874A2 Lipid-based nitric oxide donors |
| 07/25/2002 | WO2002056867A2 Extended release pharmaceutical compositions containing beta-lactam antibiotics |
| 07/25/2002 | WO2002056866A1 A method for the preparation of nanoparticles |
| 07/25/2002 | WO2002056865A2 Peat product composition, method for the production and use thereof |
| 07/25/2002 | WO2002056864A2 Differential delivery of nitric oxide |
| 07/25/2002 | WO2002056863A2 Sustained release drug delivery devices |